References
- Fine PENI, Clarkson JA. Reflections on the efficacy of pertussis vaccines. Rev Infect Dis 1987; 9: 866–3.
- Public Health Laboratory Service Whooping Cough Committee and Working Party. Efficacy of whooping cough vaccines used in the United Kingdom before 1968. BMJ1973; 1:259–62.
- Krantz I, Taranger J, Trollfors B. Estimating incidence of whooping cough over time: a cross-sectional recall study of four Swedish birth cohorts. Int J Epidemiol 1989; 18: 959–63.
- WHO Meeting on Case Definition of Pertussis. MIM/EPI/ PERT/91.1. Geneva: World Health Organization, 1991.
- Pittman M. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Rev Infect Dis 1979; 1: 401–12.
- Ad Hoc Group for the Study of Pertussis Vaccines. Placebo-controlled trial of two acellular pertussis vaccines in Sweden - protective efficacy and adverse events. Lancet 1988; 1:955–60.
- Trollfors B, Taranger J, Lagergârd T, et al. A placebo-controlled trial of a pertussis toxoid vaccine. N Engl J Med 1995; 333: 1045–50.
- Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsater J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996; 334: 349–55.
- Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular and one whole-cell vaccine against pertussis. N Engl J Med 1996; 334: 341–8.
- Fine PEM. Herd immunity: history, theory, practice. Epidemiol Rev 1993; 15: 265–302.
- Schneerson R, Robbins JB, Taranger J, Lagergârd T, Trollfors B. A toxoid vaccine for pertussis as well as for diphtheria? Lessons to be relearned. Lancet 1996; 348: 1289–91.